{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:11:47Z","timestamp":1790107907481,"version":"4.0.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Biochemistry and Biophysics"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.abb.2026.111003","type":"journal-article","created":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T06:38:19Z","timestamp":1789799899000},"page":"111003","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["ROS-activated SHP-1 signaling underlies artesunate-mediated inhibition of EMT and STAT3-Driven prostate cancer progression"],"prefix":"10.1016","volume":"786","author":[{"given":"Young Yun","family":"Jung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alamelu","family":"Nachiyappan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chakrabhavi Dhananjaya","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandra Sekhar","family":"Bhol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muthu K.","family":"Shanmugam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kodappully Sivaraman","family":"Siveen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan Prem","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amudha","family":"Deivasigamani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanchugarakoppal S.","family":"Rangappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kam Man","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2882-0612","authenticated-orcid":false,"given":"Kwang Seok","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.abb.2026.111003_bib2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.14740\/wjon1191","article-title":"Epidemiology of prostate cancer","volume":"10","author":"Rawla","year":"2019","journal-title":"World J. Oncol."},{"issue":"12","key":"10.1016\/j.abb.2026.111003_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2022.119344","article-title":"Nimbolide enhances the antitumor effect of docetaxel via abrogation of the NF-\u03baB signaling pathway in prostate cancer preclinical models","volume":"1869","author":"Zhang","year":"2022","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"issue":"11","key":"10.1016\/j.abb.2026.111003_bib5","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1002\/iub.2555","article-title":"Crocetin imparts antiproliferative activity via inhibiting STAT3 signaling in hepatocellular carcinoma","volume":"73","author":"Mohan","year":"2021","journal-title":"IUBMB Life"},{"issue":"21","key":"10.1016\/j.abb.2026.111003_bib6","doi-asserted-by":"crossref","first-page":"5479","DOI":"10.3390\/cancers13215479","article-title":"Tris(dibenzylideneacetone)dipalladium(0) (Tris DBA) abrogates tumor progression in hepatocellular carcinoma and multiple myeloma preclinical models by regulating the STAT3 signaling pathway","volume":"13","author":"Arora","year":"2021","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.abb.2026.111003_bib7","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","article-title":"Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer","volume":"15","author":"Johnson","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.abb.2026.111003_bib8","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.biochi.2020.05.006","article-title":"Vitexin abrogates invasion and survival of hepatocellular carcinoma cells through targeting STAT3 signaling pathway","volume":"175","author":"Lee","year":"2020","journal-title":"Biochimie"},{"issue":"49","key":"10.1016\/j.abb.2026.111003_bib9","doi-asserted-by":"crossref","first-page":"34296","DOI":"10.1074\/jbc.M114.601104","article-title":"Development of a novel azaspirane that targets the janus kinase-signal transducer and activator of transcription (STAT) pathway in hepatocellular carcinoma <em>in vitro and in vivo","volume":"289","author":"Mohan","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.abb.2026.111003_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.114168","article-title":"STAT3 signaling in prostate cancer progression and therapy resistance: an oncogenic pathway with diverse functions","volume":"158","author":"Sadrkhanloo","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.abb.2026.111003_bib11","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.semcancer.2021.05.006","article-title":"Bacteria as a treasure house of secondary metabolites with anticancer potential","volume":"86","author":"Mohan","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.abb.2026.111003_bib12","article-title":"Natural compounds targeting nuclear receptors for effective cancer therapy","author":"Hegde","year":"2022","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.abb.2026.111003_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2018.00309","article-title":"Endophytic fungi\u2014alternative sources of cytotoxic compounds: a review","volume":"9","author":"Uzma","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"23","key":"10.1016\/j.abb.2026.111003_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27238367","article-title":"Natural products as anticancer agents: current status and future perspectives","volume":"27","author":"Naeem","year":"2022","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.abb.2026.111003_bib15","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2174\/1871520619666191015103712","article-title":"Anticancer potential of dietary natural products: a comprehensive review","volume":"20","author":"Ahmad","year":"2020","journal-title":"Anti Cancer Agents Med. Chem."},{"key":"10.1016\/j.abb.2026.111003_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.789284","article-title":"Artesunate inhibits the growth behavior of docetaxel-resistant prostate cancer cells","volume":"12","author":"Vakhrusheva","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.abb.2026.111003_bib17","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.leukres.2017.09.022","article-title":"Artesunate induces apoptosis via inhibition of STAT3 in THP-1 cells","volume":"62","author":"Tan","year":"2017","journal-title":"Leuk. Res."},{"issue":"2","key":"10.1016\/j.abb.2026.111003_bib18","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1007\/s43440-021-00230-6","article-title":"Artesunate inhibits melanoma progression in vitro via suppressing STAT3 signaling pathway","volume":"73","author":"Berk\u00f6z","year":"2021","journal-title":"Pharmacol. Rep."},{"issue":"22","key":"10.1016\/j.abb.2026.111003_bib19","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.2174\/1568026616666160212122820","article-title":"Artesunate as an anti-cancer agent targets stat-3 and favorably suppresses hepatocellular carcinoma","volume":"16","author":"Ilamathi","year":"2016","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.abb.2026.111003_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2021.110167","article-title":"Artesunate induces apoptosis, autophagy and ferroptosis in diffuse large B cell lymphoma cells by impairing STAT3 signaling","volume":"88","author":"Chen","year":"2021","journal-title":"Cell. Signal."},{"issue":"12","key":"10.1016\/j.abb.2026.111003_bib21","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1038\/s41401-020-0395-5","article-title":"Synergistic antitumor activity of sorafenib and artesunate in hepatocellular carcinoma cells","volume":"41","author":"Yao","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"issue":"8","key":"10.1016\/j.abb.2026.111003_bib22","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.3390\/cancers13081885","article-title":"KEAP1 is required for artesunate anticancer activity in non-small-cell lung cancer","volume":"13","author":"Hill","year":"2021","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.abb.2026.111003_bib23","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1039\/C5NJ02925B","article-title":"Synthesis and antiproliferative efficiency of novel bis(imidazole-1-yl)vinyl-1,2,4-oxadiazoles","volume":"40","author":"Nandeesh","year":"2016","journal-title":"New J. Chem."},{"key":"10.1016\/j.abb.2026.111003_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2018.01125","article-title":"N-Substituted Pyrido-1,4-Oxazin-3-Ones induce apoptosis of hepatocellular carcinoma cells by targeting NF-\u03baB signaling pathway","volume":"9","author":"Mohan","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"12","key":"10.1016\/j.abb.2026.111003_bib25","doi-asserted-by":"crossref","first-page":"3824","DOI":"10.3390\/molecules27123824","article-title":"Euphorbiasteroid abrogates EGFR and Wnt\/\u03b2-Catenin signaling in non-small-cell lung cancer cells to impart anticancer activity","volume":"27","author":"Kim","year":"2022","journal-title":"Molecules"},{"issue":"7","key":"10.1016\/j.abb.2026.111003_bib26","doi-asserted-by":"crossref","first-page":"891","DOI":"10.3390\/biom12070891","article-title":"2,3,5,6-Tetramethylpyrazine targets epithelial-mesenchymal transition by abrogating manganese superoxide dismutase expression and TGF\u03b2-Driven signaling cascades in Colon cancer cells","volume":"12","author":"Jung","year":"2022","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.abb.2026.111003_bib27","article-title":"Paradoxical functions of long noncoding RNAs in modulating STAT3 signaling pathway in hepatocellular carcinoma","volume":"1876","author":"Mohan","year":"2021","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"issue":"21","key":"10.1016\/j.abb.2026.111003_bib28","doi-asserted-by":"crossref","first-page":"35376","DOI":"10.18632\/oncotarget.15686","article-title":"Epithelial-mesenchymal transition in prostate cancer: an overview","volume":"8","author":"Montanari","year":"2017","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.abb.2026.111003_bib29","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00280-018-3533-8","article-title":"A phase I study of intravenous artesunate in patients with advanced solid tumor malignancies","volume":"81","author":"Deeken","year":"2018","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"2","key":"10.1016\/j.abb.2026.111003_bib30","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s10549-017-4261-1","article-title":"Prospective open uncontrolled phase I study to define a well-tolerated dose of oral artesunate as add-on therapy in patients with metastatic breast cancer (ARTIC M33\/2)","volume":"164","author":"von Hagens","year":"2017","journal-title":"Breast Cancer Res. Treat."},{"issue":"1","key":"10.1016\/j.abb.2026.111003_bib31","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1600-065X.2008.00760.x","article-title":"SHP-1 and SHP-2 in T cells: two phosphatases functioning at many levels","volume":"228","author":"Lorenz","year":"2009","journal-title":"Immunol. Rev."},{"issue":"6","key":"10.1016\/j.abb.2026.111003_bib32","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.3390\/ijms18061234","article-title":"Alteration of SHP-1\/p-STAT3 signaling: a potential target for anticancer therapy","volume":"18","author":"Huang","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.abb.2026.111003_bib33","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1210\/en.2008-1241","article-title":"S-glutathionylation impairs signal transducer and activator of transcription 3 activation and signaling","volume":"150","author":"Xie","year":"2009","journal-title":"Endocrinology"},{"issue":"8","key":"10.1016\/j.abb.2026.111003_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0000693","article-title":"Artesunate induces ROS-mediated apoptosis in doxorubicin-resistant T leukemia cells","volume":"2","author":"Efferth","year":"2007","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.abb.2026.111003_bib35","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s00280-009-1095-5","article-title":"Artesunate induces oncosis-like cell death in vitro and has antitumor activity against pancreatic cancer xenografts in vivo","volume":"65","author":"Du","year":"2010","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"2","key":"10.1016\/j.abb.2026.111003_bib36","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.yexcr.2016.06.012","article-title":"Artesunate induces ROS-dependent apoptosis via a Bax-mediated intrinsic pathway in Huh-7 and Hep3B cells","volume":"347","author":"Pang","year":"2016","journal-title":"Exp. Cell Res."},{"issue":"41","key":"10.1016\/j.abb.2026.111003_bib37","doi-asserted-by":"crossref","first-page":"5252","DOI":"10.1038\/onc.2014.445","article-title":"SHP-1 is a negative regulator of epithelial-mesenchymal transition in hepatocellular carcinoma","volume":"34","author":"Fan","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.abb.2026.111003_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-1119(03)00400-1","article-title":"The function of the protein tyrosine phosphatase SHP-1 in cancer","volume":"306","author":"Wu","year":"2003","journal-title":"Gene"},{"issue":"3","key":"10.1016\/j.abb.2026.111003_bib39","first-page":"2339","article-title":"Reactive oxygen species induce epithelial-mesenchymal transition, glycolytic switch, and mitochondrial repression through the Dlx-2\/Snail signaling pathways in MCF-7 cells","volume":"20","author":"Lee","year":"2019","journal-title":"Mol. Med. Rep."},{"issue":"5","key":"10.1016\/j.abb.2026.111003_bib40","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.cell.2005.05.016","article-title":"Redox redux: revisiting PTPs and the control of cell signaling","volume":"121","author":"Tonks","year":"2005","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.abb.2026.111003_bib41","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S1097-2765(02)00445-8","article-title":"Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo","volume":"9","author":"Meng","year":"2002","journal-title":"Mol. Cell"},{"key":"10.1016\/j.abb.2026.111003_bib42","unstructured":"M. Ashrafizadeh, C.D. Mohan, S. Rangappa, A. Zarrabi, K. Hushmandi, A.P. Kumar, G. Sethi, K.S. Rangappa, Noncoding RNAs as regulators of STAT3 pathway in gastrointestinal cancers: roles in cancer progression and therapeutic response, Medicinal Research Reviews n\/a(n\/a)."}],"container-title":["Archives of Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986126002754?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986126002754?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T19:49:30Z","timestamp":1790106570000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003986126002754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":40,"alternative-id":["S0003986126002754"],"URL":"https:\/\/doi.org\/10.1016\/j.abb.2026.111003","relation":{},"ISSN":["0003-9861"],"issn-type":[{"value":"0003-9861","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ROS-activated SHP-1 signaling underlies artesunate-mediated inhibition of EMT and STAT3-Driven prostate cancer progression","name":"articletitle","label":"Article Title"},{"value":"Archives of Biochemistry and Biophysics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abb.2026.111003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111003"}}